f17464
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01689038)
Timeline
Indications
Mechanism of action
- Dopamine D3 receptorANTAGONIST
DRD3 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- f17464
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02151656 | Phase 2 | Jun 1, 2014 | Pierre Fabre |
| NCT01689038 | Phase 1 | Nov 1, 2012 | Pierre Fabre |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pierre Fabre | For profit | 2 | 2 | 2 | 2012 |
1 organizations
Page 1 / 1